Organization & Governance
SIGID will be composed of a Governing Board (GB) comprising all Directors of the different laboratories and Legal representative of CNRS, DBT, Universities and 4 external scientists (2 Indians, 2 Frenchs). The GB will plan, organize, direct and monitor the integrated efforts to achieve the IAL goals. The GB will congregate once a year at the LIA annual meeting, and by phone or video conferencing in case of an emergency situation. The major decisions in the project such as revision of IAL Agreement, changes in the partnership, validation of the financial allocation of the LIA will be taken by the GB. The detailed roles and rules of the GB will be defined in a Memorandum Of Understanding (MOU) between of partners for collaboration in the area of mutual interests. The GB will generate an annual reporting to DBT and CNRS.
Executive Committee (EC)
It is responsible for the major scientific decisions such as the validation of the project implementation plan and all issues in which collective responsibility is involved, the financial allocation of the funds, validation of the meeting organisation, implementation plan and all issues in which collective responsibility is involved. It will also ensure a proper communication and diffusion of information between the partners.
A Cross-Cultural Task Force
is in charge of facilitating the interactions between French and Indian partners in the conduct of the project and within all types of exchanges.
A Clinical Task force
is responsible for obtaining the relevant clearances from the appropriate regulatory authorities (Ethics committees, Institutional Review Boards, etc) for sample collection and transport.
A Technology Task Force
is in charge of all question linked to the high level of technology required in the LIA project for data acquisition, as well as the fast evolution of such technologies and the frequent emergence of novel technologies and methodologies
It is under the responsibility of the two co-ordinators. They ensure communication and facilitate diffusion and information between the partners and will be responsible for overall legal, contractual, ethical, financial and administrative management of the project. The Co-Coordinators act as the intermediary between the consortium and CNRS and DBT. An internal reporting system will be established to ensure a smooth operation of the project. A dedicated collaborative platform will be used to ensure an efficient management.
- Basic and Clinical Immunology in Parasitic Diseases (BCIP)
- Center for Infection and Immunity of Lille (CIIL)
- Department of Biological Sciences - TIFR
- Immunity & Infection (NII)
- Immunobiology of Metazoan Parasites (ILS)
- Immunology - Immunopathology - Immunotherapy (i3)
- Infection and Immunity (NCCS)
- Institute of Life Sciences (ILS)
- Integrative Immunology (i2)
- Ispat General Hospital, Rourkela (IGH)
- Molecular Parasitology - TIFR
- National Centre for Cell Science (NCCS)
- National Institute of Immunology (NII)
- Reproduction, Development & Cell Biology (NII)
- S.C.B. Medical College
- Structural Biology (NCCS)
- Systems Epigenomics